Published in J Pediatr on February 01, 1980
Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest (1991) 3.71
Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol (2007) 3.19
Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res (2011) 2.51
Parainfluenza viruses. Clin Microbiol Rev (2003) 2.39
Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child (1994) 2.13
Detection, pathogenesis, and therapy of respiratory syncytial virus infections. Clin Microbiol Rev (1988) 1.92
Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev (1999) 1.83
Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review. Crit Care (2006) 1.72
Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis. J Infect Dis (2011) 1.59
A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge. J Virol (2006) 1.58
Respiratory syncytial virus vaccines. Clin Microbiol Rev (1998) 1.38
Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice. J Virol (1987) 1.38
Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog (2011) 1.28
Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit. J Clin Microbiol (1998) 1.27
Rapid detection of parainfluenza virus type 3 RNA in respiratory specimens: use of reverse transcription-PCR-enzyme immunoassay. J Clin Microbiol (1994) 1.25
Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus. Expert Rev Vaccines (2008) 1.23
Respiratory syncytial virus vaccine development. Expert Rev Vaccines (2011) 1.18
Respiratory syncytial virus infection in human bone marrow stromal cells. Am J Respir Cell Mol Biol (2010) 1.16
Role of T cells in virus control and disease after infection with pneumonia virus of mice. J Virol (2008) 1.14
Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. J Clin Invest (1990) 1.13
Secretory immunological response in infants and children to parainfluenza virus types 1 and 2. Infect Immun (1980) 1.12
Interactions between RSV infection, asthma, and atopy: unraveling the complexities. J Exp Med (2002) 1.11
Nosocomial transmission of respiratory syncytial virus in immunocompromised adults. J Clin Microbiol (1991) 1.09
Characterization of a novel respiratory syncytial virus-specific human cytotoxic T-lymphocyte epitope. J Virol (2000) 1.09
Polarity of human parainfluenza virus type 3 infection in polarized human lung epithelial A549 cells: role of microfilament and microtubule. J Virol (2001) 1.09
Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus. Proc Natl Acad Sci U S A (1986) 1.09
Mixed viral infections: detection and management. Clin Microbiol Rev (1994) 1.05
Viral infection in cystic fibrosis. J R Soc Med (1986) 1.04
Viral infection of the lung: host response and sequelae. J Allergy Clin Immunol (2013) 1.01
Isolation of highly fusogenic variants of simian virus 5 from persistently infected cells that produce and respond to interferon. J Virol (1997) 0.98
HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein. J Virol (2000) 0.97
Respiratory syncytial virus: current progress in vaccine development. Viruses (2013) 0.95
Development of cell-mediated cytotoxic activity in the respiratory tract after experimental infection with respiratory syncytial virus. Clin Exp Immunol (1985) 0.95
In vivo selection of respiratory syncytial viruses resistant to palivizumab. J Virol (2005) 0.89
Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells. J Virol (2003) 0.88
Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates. Mol Ther Methods Clin Dev (2015) 0.86
Effects of aging on the adaptive immune response to respiratory virus infections. Aging health (2009) 0.86
Phenotypic analysis of local cellular responses in calves infected with bovine respiratory syncytial virus. Immunology (1999) 0.86
Antiviral B cell and T cell immunity in the lungs. Nat Immunol (2015) 0.86
Altered cardiac rhythm in infants with bronchiolitis and respiratory syncytial virus infection. BMC Infect Dis (2010) 0.83
Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection. J Virol (2010) 0.83
Vaccination against RSV: is maternal vaccination a good alternative to other approaches? Hum Vaccin Immunother (2013) 0.83
Primary cytotoxic T-cell responses to bovine respiratory syncytial virus in calves. Immunology (1996) 0.82
Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice. J Virol (2009) 0.82
Pathogens in children with severe combined immune deficiency disease or AIDS. CMAJ (1986) 0.81
Think outside the box: extrapulmonary manifestations of severe respiratory syncytial virus infection. Crit Care (2006) 0.80
Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections. Lung (1990) 0.80
Why do viruses make infants wheeze? Arch Dis Child (1996) 0.79
Evaluation of a nested reverse transcription-PCR assay based on the nucleoprotein gene for diagnosis of spontaneous and experimental bovine respiratory syncytial virus infections. J Clin Microbiol (1999) 0.77
In situ evolution of virus-specific cytotoxic T cell responses in the lung. J Virol (2013) 0.77
Diagnosis and treatment of viral infections. Bull N Y Acad Med (1987) 0.75
Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes. Cytotherapy (2016) 0.75
Immunity to viruses. Arch Dis Child (1989) 0.75
Cationic liposome-mediated enhanced generation of human HLA-restricted RSV-specific CD8+ CTL+. J Clin Immunol (2002) 0.75
Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet (1978) 10.25
Evolution and transmission of stable CTL escape mutations in HIV infection. Nature (2001) 6.57
Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med (2010) 6.38
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol (1996) 5.09
The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr (1973) 4.22
A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med (2000) 4.14
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (1989) 3.54
Detection of respiratory syncytial virus in nasal secretions from infants by enzyme-linked immunosorbent assay. J Infect Dis (1979) 3.49
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A (1967) 3.47
Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J Clin Microbiol (1982) 3.22
Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis (1974) 2.55
Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (1999) 2.51
The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis (1978) 2.32
Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med (2000) 2.31
Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. J Infect Dis (1986) 2.26
Viral and bacterial infections in adults with chronic asthma. Am Rev Respir Dis (1979) 2.25
Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J Virol (1993) 2.21
A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus. J Pediatr (1990) 2.09
Coronaviridae: second report. Intervirology (1978) 2.05
Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr (1977) 2.00
Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. N Engl J Med (1992) 1.92
Chlamydial infection of mothers and their infants. J Pediatr (1979) 1.89
The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics (1980) 1.89
Summary of a workshop on new and useful methods in viral diagnosis. J Infect Dis (1978) 1.87
Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (2000) 1.87
Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. J Virol (2000) 1.84
Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease. Proc Natl Acad Sci U S A (1967) 1.82
Role of infection in chronic bronchitis. Am Rev Respir Dis (1976) 1.81
Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group. J Pediatr (1996) 1.79
Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J Virol (2000) 1.79
Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infect Immun (1979) 1.70
Seroepidemiologic studies of coronavirus infection in adults and children. Am J Epidemiol (1970) 1.66
Neonatal Haemophilus influenzae infection. Report of eight cases and review of the literature. Am J Dis Child (1975) 1.65
Cardiac morbidity and related mortality in children with HIV infection. JAMA (1993) 1.65
Bending-related faulting and mantle serpentinization at the Middle America trench. Nature (2003) 1.64
Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr (1978) 1.61
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58
Is it time to give influenza vaccine to healthy infants? N Engl J Med (2000) 1.58
Coronaviridae. Intervirology (1975) 1.55
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52
Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. Prog Med Virol (1980) 1.51
Morphogenesis of avian infectious bronchitis virus and a related human virus (strain 229E). J Virol (1967) 1.49
The preparation and properties of adenovirus cores. J Gen Virol (1971) 1.49
Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses. J Immunol (1969) 1.48
Isolation from man of "avian infectious bronchitis virus-like" viruses (coronaviruses) similar to 229E virus, with some epidemiological observations. J Infect Dis (1969) 1.41
Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet (1990) 1.41
Evaluation of human and simian immunodeficiency virus plaque and neutralization assays. J Gen Virol (1989) 1.39
Altered histopathology in protein-deprived mice during Sendai virus pneumonia: evidence for delayed inflammatory response and recovery. J Infect Dis (1992) 1.39
Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: a report from the Children's Cancer Group. Int J Radiat Oncol Biol Phys (1996) 1.39
Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981-1987. J Infect Dis (1989) 1.39
Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children. J Virol (2003) 1.38
Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol. Am J Dis Child (1984) 1.38
A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol (1999) 1.38
Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation. Immunol Lett (2001) 1.37
Multicenter study of strains of respiratory syncytial virus. J Infect Dis (1991) 1.34
Comparison of cynomolgus and rhesus monkey kidney cells for recovery of viruses from clinical specimens. J Clin Microbiol (1979) 1.33
Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am J Cardiol (1989) 1.33
Comparison of washed nasopharyngeal cells and whole nasal secretions for detection of respiratory syncytial virus antigens by enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 1.28
Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J Infect Dis (1992) 1.27
Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus. J Virol (1988) 1.26
Evaluation of a commercially available direct immunofluorescent staining reagent for the detection of respiratory syncytial virus in respiratory secretions. J Clin Microbiol (1986) 1.23
The association of rhinoviruses with lower respiratory tract disease in hospitalized patients. J Med Virol (1986) 1.23
Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr (1993) 1.22
Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: development and description. J Clin Microbiol (1982) 1.20
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group. N Engl J Med (1991) 1.20
Monoclonal antibodies for the rapid diagnosis of respiratory syncytial virus infection by immunofluorescence. Diagn Microbiol Infect Dis (1984) 1.16
Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study. Leuk Lymphoma (1996) 1.16
The prenatal exclusion test for Huntington's disease: experience in the west of Scotland, 1986-1993. J Med Genet (1995) 1.16
Summary of a workshop on new and useful methods in rapid viral diagnosis. J Infect Dis (1984) 1.13
Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells. J Gen Virol (1987) 1.13
A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery. J Pediatr (1984) 1.12
Secretory immunological response in infants and children to parainfluenza virus types 1 and 2. Infect Immun (1980) 1.12
Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol (1990) 1.12
Type A2 influenza viral infections in children. Am J Dis Child (1978) 1.12
The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics (2001) 1.10
Characterization of a novel respiratory syncytial virus-specific human cytotoxic T-lymphocyte epitope. J Virol (2000) 1.09
Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group. J Allergy Clin Immunol (2000) 1.09
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Standard percutaneous revaccination of children who receive primary percutaneous vaccination. J Infect Dis (1977) 1.08
Oral ribavirin therapy for subacute sclerosing panencephalitis. J Infect Dis (1989) 1.08
Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis. Ann Neurol (1994) 1.07
Selective primary health care: strategies for control of disease in the developing world. XXI. Acute respiratory infections. Rev Infect Dis (1985) 1.07
The use of gowns and masks to control respiratory illness in pediatric hospital personnel. J Pediatr (1981) 1.06
Viral vaccination via the mucosal routes. Rev Infect Dis (1980) 1.05
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Primary percutaneous vaccination. J Infect Dis (1977) 1.05
Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1. J Infect Dis (1999) 1.04
Risk of illness after exposure to a pediatric office. N Engl J Med (1985) 1.04
Respiratory syncytial virus infections in infants and children: diagnosis and treatment. Pediatr Rev (1987) 1.03
Neonatal mastitis. Clin Pediatr (Phila) (1986) 1.03
Polymerase chain reaction in detecting HIV infection among seropositive infants: relation to clinical status and age and to results of other assays. J Acquir Immune Defic Syndr (1992) 1.03
Enterovirus infections in neonates. J Pediatr (1976) 1.03
Lymphocytotoxic antibodies in multiple sclerosis. Clin Immunol Immunopathol (1977) 1.02
Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children. J Infect Dis (2000) 1.02
Maternal and perinatal factors related to maternal-infant transmission of HIV-1 in the P2C2 HIV study: the role of EBV shedding. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV-1 Infection (P2C2 HIV) Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.01